Original language | English |
---|---|
Journal | Arzneimittel-Forschung/Drug Research |
Volume | 53 |
Issue number | 6 |
Pages (from-to) | 449-466 |
Number of pages | 18 |
ISSN | 0004-4172 |
Publication status | Published - 2003 |
Workshop: Therapeutic oligonucleotides in drug development
Georg Sczakiel*, Hermona Soreq, Beate Greiner, Volker Gekeler, Marc Lemaitre, Wee Sung Park, Naoko Miyano-Kurosaki, Masaaki Hayafune, Hiroshi Takaku, Arndt Borkhardt, Brian S. Sproat, Peter E. Nielsen, Gunther Hartmann, Stefan Endres, Klaus Heckelsmiller, Katharina Ralla, Sebastian Beck, Bences Sipos, Angelika Schlamp, Evelyn Tuma
*Corresponding author for this work
- Hebrew University of Jerusalem
- Sanofi-Aventis Deutschland GmbH
- ALTANA Pharma AG
- Eurogentec S.A.
- Chiba Institute of Technology
- University of Giessen
- RNA-TEC NV
- Panum Institute
- Ludwig-Maximilians-Universität
- University of Kiel
- Pfizer Inc.
- Vancouver General Hospital
- University of British Columbia
- University of Vienna
- Kobe University Graduate School of Medicine
- Charite - Universitatsmedizin Berlin
- University of Innsbruck
- University of Regensburg
- Antisense Pharma GmbH
- Federal Institute for Vaccines and Biomedicines
- Max Planck Institute